Biomarker Predicts Which Stage Ii Colon Cancer Patients May Benefit From Chemotherapy
Wednesday, January 20, 2016 - 17:20
in Health & Medicine
Researchers from Columbia, Stanford, UC-Davis, and other institutions identified a biomarker that predicts which stage II colon cancer patients may benefit from adjuvant chemotherapy to prevent a disease recurrence.